Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Freitag

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Radiation Oncology (London, England)|August 7, 2024
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on <sup>18</sup>F-PSMA-1007 PETJulius C Holzschuh, Michael Mix, Martin T Freitag, et al.
European Urology|April 13, 2017
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary BiopsiesJan Philipp Radtke, Manuel Wiesenfarth, Claudia Kesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2016
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in <sup>68</sup>Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIMartin T Freitag, Jan P Radtke, Ali Afshar-Oromieh, et al.
European Urology|January 27, 2016
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy SpecimenJan P Radtke, Constantin Schwab, Maya B Wolf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Radiation Oncology (London, England)|August 7, 2024
The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on <sup>18</sup>F-PSMA-1007 PETJulius C Holzschuh, Michael Mix, Martin T Freitag, et al.
European Urology|April 13, 2017
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary BiopsiesJan Philipp Radtke, Manuel Wiesenfarth, Claudia Kesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 19, 2016
Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in <sup>68</sup>Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRIMartin T Freitag, Jan P Radtke, Ali Afshar-Oromieh, et al.
European Urology|January 27, 2016
Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy SpecimenJan P Radtke, Constantin Schwab, Maya B Wolf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 17, 2025
Safety and quality of life of PSMA-PET- and MRI-based focal dose escalated radiotherapy for intermediate- and high-risk prostate cancer: Primary endpoint analysis of the bi-centric phase II HypoFocal trial (ARO2020-01)Simon K B Spohn, Constantinos Zamboglou, Sophia L Bürkle, et al.
Pageof 6